Literature DB >> 26264677

Evidence for fumonisin inhibition of ceramide synthase in humans consuming maize-based foods and living in high exposure communities in Guatemala.

Ronald T Riley1, Olga Torres2,3, Jorge Matute3, Simon G Gregory4, Allison E Ashley-Koch4, Jency L Showker1, Trevor Mitchell1, Kenneth A Voss1, Joyce R Maddox5, Janee B Gelineau-van Waes5.   

Abstract

SCOPE: Fumonisin (FB) occurs in maize and is an inhibitor of ceramide synthase (CerS). We determined the urinary FB1 (UFB1 ) and sphingoid base 1-phosphate levels in blood from women consuming maize in high and low FB exposure communities in Guatemala. METHODS AND
RESULTS: FB1 intake was estimated using the UFB1 . Sphinganine 1-phosphate (Sa 1-P), sphingosine 1-phosphate (So 1-P), and the Sa 1-P/So 1-P ratio were determined in blood spots collected on absorbent paper at the same time as urine collection. In the first study, blood spots and urine were collected every 3 months (March 2011 to February 2012) from women living in low (Chimaltenango and Escuintla) and high (Jutiapa) FB exposure communities (1240 total recruits). The UFB1 , Sa 1-P/So 1-P ratio, and Sa 1-P/mL in blood spots were significantly higher in the high FB1 intake community compared to the low FB1 intake communities. The results were confirmed in a follow-up study (February 2013) involving 299 women living in low (Sacatepéquez) and high (Santa Rosa and Chiquimula) FB exposure communities.
CONCLUSIONS: High levels of FB1 intake are correlated with changes in Sa 1-P and the Sa 1-P/So 1-P ratio in human blood in a manner consistent with FB1 inhibition of CerS.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Ceramide synthase; Fumonisin; Maize; Sphinganine 1-phosphate; Urinary fumonisin

Mesh:

Substances:

Year:  2015        PMID: 26264677      PMCID: PMC4956729          DOI: 10.1002/mnfr.201500499

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  27 in total

1.  A blood spot method for detecting fumonisin-induced changes in putative sphingolipid biomarkers in LM/Bc mice and humans.

Authors:  Ronald T Riley; Jency L Showker; Christine M Lee; Cody E Zipperer; Trevor R Mitchell; Kenneth A Voss; Nicholas C Zitomer; Olga Torres; Jorge Matute; Simon G Gregory; Allison E Ashley-Koch; Joyce R Maddox; Nicole Gardner; Janee B Gelineau-Van Waes
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2015-04-10

2.  Essential role for sphingosine kinases in neural and vascular development.

Authors:  Kiyomi Mizugishi; Tadashi Yamashita; Ana Olivera; Georgina F Miller; Sarah Spiegel; Richard L Proia
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

3.  The kinetics of urinary fumonisin B1 excretion in humans consuming maize-based diets.

Authors:  Ronald T Riley; Olga Torres; Jency L Showker; Nicholas C Zitomer; Jorge Matute; Kenneth A Voss; Janee Gelineau-van Waes; Joyce R Maddox; Simon G Gregory; Allison E Ashley-Koch
Journal:  Mol Nutr Food Res       Date:  2012-07-20       Impact factor: 5.914

4.  Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720.

Authors:  Janee Gelineau-van Waes; Mark A Rainey; Joyce R Maddox; Kenneth A Voss; Andrew J Sachs; Nicole M Gardner; Justin D Wilberding; Ronald T Riley
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-09-18

5.  Differential sensitivity of rat kidney and liver to fumonisin toxicity: organ-specific differences in toxin accumulation and sphingoid base metabolism.

Authors:  Ronald T Riley; Kenneth A Voss
Journal:  Toxicol Sci       Date:  2006-04-12       Impact factor: 4.849

Review 6.  Maternal fumonisin exposure as a risk factor for neural tube defects.

Authors:  J Gelineau-van Waes; K A Voss; V L Stevens; M C Speer; R T Riley
Journal:  Adv Food Nutr Res       Date:  2009

7.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.

Authors:  E Wang; W P Norred; C W Bacon; R T Riley; A H Merrill
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

8.  Differential expression of sphingosine-1-phosphate receptors 1-5 in the developing nervous system.

Authors:  H Meng; V M Lee
Journal:  Dev Dyn       Date:  2009-02       Impact factor: 3.780

9.  A prospective study of growth and biomarkers of exposure to aflatoxin and fumonisin during early childhood in Tanzania.

Authors:  Candida P Shirima; Martin E Kimanya; Michael N Routledge; Chou Srey; Joyce L Kinabo; Hans-Ulrich Humpf; Christopher P Wild; Yu-Kang Tu; Yun Yun Gong
Journal:  Environ Health Perspect       Date:  2014-10-17       Impact factor: 9.031

10.  Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology.

Authors:  Jillian H Hurst; Jennifer Mumaw; David W Machacek; Carla Sturkie; Phillip Callihan; Steve L Stice; Shelley B Hooks
Journal:  BMC Neurosci       Date:  2008-12-11       Impact factor: 3.288

View more
  15 in total

1.  Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.

Authors:  Ronald T Riley; Alfred H Merrill
Journal:  J Lipid Res       Date:  2019-05-02       Impact factor: 5.922

Review 2.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

3.  Dietary Exposure to Fumonisins and Health Risk Assessment in the Sixth China Total Diet Study - China, 2015-2020.

Authors:  Shuo Zhang; Shuang Zhou; Bing Lyu; Nannan Qiu; Jingguang Li; Yunfeng Zhao; Yongning Wu
Journal:  China CDC Wkly       Date:  2021-07-16

Review 4.  Mycotoxin-Linked Mutations and Cancer Risk: A Global Health Issue.

Authors:  Theodora Ekwomadu; Mulunda Mwanza; Alfred Musekiwa
Journal:  Int J Environ Res Public Health       Date:  2022-06-24       Impact factor: 4.614

5.  Oral and Intravenous Fumonisin Exposure in Pigs-A Single-Dose Treatment Experiment Evaluating Toxicokinetics and Detoxification.

Authors:  Hanna Schertz; Jeannette Kluess; Jana Frahm; Dian Schatzmayr; Ilse Dohnal; Gerlinde Bichl; Heidi Schwartz-Zimmermann; Gerhard Breves; Sven Dänicke
Journal:  Toxins (Basel)       Date:  2018-04-05       Impact factor: 4.546

6.  Orally Administered Fumonisins Affect Porcine Red Cell Membrane Sodium Pump Activity and Lipid Profile Without Apparent Oxidative Damage.

Authors:  András Szabó; Omeralfaroug Ali; Katalin Lóki; Krisztián Balogh; Miklós Mézes; Tibor Bartók; Levente Horváth; Melinda Kovács
Journal:  Toxins (Basel)       Date:  2020-05-12       Impact factor: 4.546

7.  Mycotoxin exposure is associated with increased risk of esophageal squamous cell carcinoma in Huaian area, China.

Authors:  Kathy S Xue; Lili Tang; Guiju Sun; Shaokang Wang; Xu Hu; Jia-Sheng Wang
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

8.  Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblasts.

Authors:  Ruth R Magaye; Feby Savira; Xin Xiong; Kevin Huynh; Peter J Meikle; Christopher Reid; Bernard L Flynn; David Kaye; Danny Liew; Bing H Wang
Journal:  Int J Cardiol Heart Vasc       Date:  2021-07-06

9.  Exposure to aflatoxin and fumonisin in children at risk for growth impairment in rural Tanzania.

Authors:  Chen Chen; Nicole J Mitchell; Jean Gratz; Eric R Houpt; Yunyun Gong; Patricia A Egner; John D Groopman; Ronald T Riley; Jency L Showker; Erling Svensen; Estomih R Mduma; Crystal L Patil; Felicia Wu
Journal:  Environ Int       Date:  2018-03-13       Impact factor: 9.621

10.  Biomarker Evaluation and Toxic Effects of an Acute Oral and Systemic Fumonisin Exposure of Pigs with a Special Focus on Dietary Fumonisin Esterase Supplementation.

Authors:  Hanna Schertz; Sven Dänicke; Jana Frahm; Dian Schatzmayr; Ilse Dohnal; Gerlinde Bichl; Heidi E Schwartz-Zimmermann; Sonia Colicchia; Gerhard Breves; Jens P Teifke; Jeannette Kluess
Journal:  Toxins (Basel)       Date:  2018-07-17       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.